01 · Packaging
Packaging Pilot
For teams with a formula or current package that need format, fill-volume, MOQ and pack-out direction.


Controlled two-site BFS manufacturing
Steridose Labs delivers serum sample packaging, BFS filling, trial-kit pack-out and supplier qualification through a controlled two-site manufacturing network for overseas beauty, sourcing and R&D teams.
21
BFS blow-fill-seal lines across two factory sites
0.5–20ml
Core format review range
10,000+
Standard commercial pilot
NDA
Before formula transfer
Product system
Start with how the product will be sampled, carried and used. Manufacturing terminology comes after the project need is clear.

Three ways to begin
A finished formula, an early concept and a complete market-test kit do not need the same first conversation.
01 · Packaging
For teams with a formula or current package that need format, fill-volume, MOQ and pack-out direction.

02 · Development
For teams that need formula direction, NDA transfer or filling-fit review before commercial packaging.

03 · Market test
For private-label, distributor and turnkey partners testing a complete sample program before scale-up.

Controlled manufacturing network
Steridose Labs is the international commercial and technical team for a controlled two-site BFS manufacturing network. The network has 21 BFS blow-fill-seal lines across two factory sites. Each qualified project stays within one Steridose-led workflow while the better-fit production site is selected by formula, format, document scope, quantity and schedule. Capacity only matters when the format, formula, evidence needs and schedule can be qualified together.
Production path 01
Format-focused BFS production for qualified single-dose liquid projects.
Production path 02
Formula, laboratory and broader OEM/ODM support alongside BFS manufacturing.
Production-site selection
One Steridose brief stays within the controlled network while the better-fit production site is selected.
Commercial entry
10,000+ units is the standard commercial pilot path, with selective 5,000-unit review.
Formula confidentiality
NDA alignment can take place before proprietary formula details are transferred.
Evidence access
Facility identity, certificate scope and applicable documents are shared with qualified projects at the appropriate review stage.
From brief to scale
Each stage removes a different risk before production planning becomes expensive.
01
Share the use case, formula status, target market, format and timing.
02
Review fill volume, material route, formula handling, pack-out and document needs.
03
Align samples, approval files, MOQ, lead-time variables and commercial assumptions.
04
Use pilot feedback to plan reorders, channel expansion and the next production stage.
Decision examples
Procurement resources
Custom review can include BFS LDPE ampoules, liquid-filled swabs, trial kits, labels, pouches, cartons, inserts, pack-out and NDA formula-transfer needs.
Include the target format, liquid type, fill volume, current package, pilot quantity, market, timeline, quality-document needs and NDA status.
Standard commercial pilot production usually starts from 10,000+ units. A 5,000-unit review may be possible when formula, format, channel plan and launch use case are already clear.
Yes. Qualified projects can review relevant factory context, equipment references and quality-document direction during scoping.
Ready for qualification
Share the use case, formula status, preferred format, fill volume, target market and launch timing. Proprietary formula details can wait until NDA alignment.